title: Regulation of gluconeogenesis by glycerol and its phosphorylated derivatives.
abstract: Glycerol, glycerol-3-phosphate (G3P), and dihydroxyacetone phosphate (DHAP) were evaluated as inhibitors of gluconeogenesis on rat liver enzymes in vitro, and for their effects on glucose formation in vivo in well-nourished and malnourished rats. DHAP was more potent as an inhibitor than G3P on fructose-1,6-diphosphatase (FDPase), phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase (G6Pase). The I50 for DHAP was 2, 8, and 9 x 10(-3) M, respectively. No effect was observed on rat liver pyruvate carboxylase (PC). Glycerol was a weak inhibitor of FDPase and PEPCK, but did not inhibit PC and G6Pase. In vivo, when G3P was injected before a parenteral L-alanine (Ala) challenge, it produced a hypoglycemic effect in malnourished rats and a lesser, but noticeable, blood glucose level reduction in well-fed animals. Glycerol caused a smaller reduction in glucose formation from Ala. No comparable effects were observed after a fructose pretreatment. These results underscore the potential hypoglycemic effects of phosphorylated glycerol metabolites and identify the steps in gluconeogenesis where this action is exerted. The study also stresses the nutritional component in the glycerol intolerance syndrome, apparent from the far more severe effects observed in malnourished rats given G3P or glycerol prior to Ala.
authors.forename: R A
authors.initials: RA
authors.lastname: Wapnir
authors.forename: L
authors.initials: L
authors.lastname: Stiel
mesh_terms: D000409:Alanine / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D004099:Dihydroxyacetone Phosphate / Q000494:pharmacology*; D005632:Fructose / Q000494:pharmacology; D006597:Fructose-Bisphosphatase / Q000037:antagonists & inhibitors; D005943:Gluconeogenesis / Q000187:drug effects*; D005952:Glucose-6-Phosphatase / Q000037:antagonists & inhibitors; D005990:Glycerol / Q000494:pharmacology*; D005994:Glycerophosphates / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008297:Male; D010729:Phosphoenolpyruvate Carboxykinase (GTP) / Q000037:antagonists & inhibitors; D011502:Protein-Energy Malnutrition / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D014306:Trioses / Q000494:pharmacology*
chemical_list: D001786:Blood Glucose; D005994:Glycerophosphates; D014306:Trioses; D005632:Fructose; D004099:Dihydroxyacetone Phosphate; C029620:alpha-glycerophosphoric acid; D006597:Fructose-Bisphosphatase; D005952:Glucose-6-Phosphatase; D010729:Phosphoenolpyruvate Carboxykinase (GTP); D000409:Alanine; D005990:Glycerol